Ipratropium inhalation is used to prevent bronchospasm, or narrowing airways in the lungs, in people with bronchitis, emphysema, or COPD (chronic obstructive pulmonary disease)
Ipratropium Bromidebelongs to Anti-Asthmatic Therapeutic Category.
Aarti Healthcare Division of Aarti Industries Limited manufactures Ipratropium with an annual capacity of 6000 Kgs.
Ipratropium is available in the following Specifications/Grades.
|EDMF (CTD)||CEP 2008-150|
|COS||RO-CEP 2008-150-REV 01|
One of the principles that enables Aarti to offer our customers the utmost in supply reliability and to further consolidate our competitive position is our backward integration of all the key intermediates that go into manufacturing of APIs.
|Budesonide||Bambuterol HCL||R-Salbutamol Sulphate|
|Levalbuterol HCL||Levalbuterol Tartrate||Salmeterol Xinafoate|
|Ipratropium Bromide||Ciclesonide||Fluticasone Propionate|
|Fluticasone Furoate||Mometasone Furoate Monohydrate||Formoterol Fumarate|